Biofrontera (BFRI) Gross Profit: 2020-2025
Historic Gross Profit for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to $4.9 million.
- Biofrontera's Gross Profit rose 19.54% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 2.39%. This contributed to the annual value of $18.7 million for FY2024, which is 12.55% up from last year.
- According to the latest figures from Q3 2025, Biofrontera's Gross Profit is $4.9 million, which was down 22.62% from $6.4 million recorded in Q2 2025.
- Biofrontera's 5-year Gross Profit high stood at $12.0 million for Q4 2023, and its period low was -$7.3 million during Q4 2022.
- Its 3-year average for Gross Profit is $4.6 million, with a median of $4.1 million in 2024.
- The largest annual percentage gain for Biofrontera's Gross Profit in the last 5 years was 263.03% (2023), contrasted with its biggest fall of 205.74% (2023).
- Quarterly analysis of 5 years shows Biofrontera's Gross Profit stood at $9.0 million in 2021, then tumbled by 181.57% to -$7.3 million in 2022, then surged by 263.03% to $12.0 million in 2023, then crashed by 39.02% to $7.3 million in 2024, then climbed by 19.54% to $4.9 million in 2025.
- Its last three reported values are $4.9 million in Q3 2025, $6.4 million for Q2 2025, and $5.3 million during Q1 2025.